A phase I/II trial of CD3/CD28 activated T cells (Xcellerated T Cells) in patients with hormone refractory prostate cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.2549 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 2549-2549 ◽

Author(s):

M. L. Glode ◽

A. Pantuck ◽

C. S. Higano ◽

J. Meyer ◽

L. Hami ◽

...

Keyword(s):

Prostate Cancer ◽

T Cells ◽

Phase I ◽

Hormone Refractory Prostate Cancer ◽

Activated T Cells ◽

Hormone Refractory

Download Full-text

A phase I/II trial of CD3/CD28 activated T cells (Xcellerated T Cells) in patients with hormone refractory prostate cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.2549 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 2549-2549

Author(s):

M. L. Glode ◽

A. Pantuck ◽

C. S. Higano ◽

J. Meyer ◽

L. Hami ◽

...

Keyword(s):

Prostate Cancer ◽

T Cells ◽

Phase I ◽

Hormone Refractory Prostate Cancer ◽

Activated T Cells ◽

Hormone Refractory

Download Full-text

604: A Phase I Trial of Vaccination of Personalized Peptides for HLA-A2/A24 Positive Patients with Hormone-Refractory Prostate Cancer

The Journal of Urology ◽

10.1016/s0022-5347(18)30844-9 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 202-202

Author(s):

Hirotsugu Uemura ◽

Motoyoshi Tanaka ◽

Shigeya Uejima ◽

Takafumi Minami ◽

Kiyohide Fujimoto ◽

...

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Phase I Trial ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

A Phase I Clinical Trial of CD1c (BDCA-1)+ Dendritic Cells Pulsed With HLA-A*0201 Peptides for Immunotherapy of Metastatic Hormone Refractory Prostate Cancer

Journal of Immunotherapy ◽

10.1097/cji.0000000000000063 ◽

2015 ◽

Vol 38 (2) ◽

pp. 71-76 ◽

Author(s):

Rebecca L. Prue ◽

Frank Vari ◽

Kristen J. Radford ◽

Hui Tong ◽

Melinda Y. Hardy ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Dendritic Cells ◽

Phase I ◽

Phase I Clinical Trial ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

1174. Correlation of Therapeutic Responses with Tumor Associated Parameters: A Phase I Clinical Trial of Adenovirus Osteocalcin Promoter Driven Herpes Simplex Virus Thymidine Kinase (Ad-OC-TK) for Metastatic and Localized Hormone Refractory Prostate Cancer

Molecular Therapy ◽

10.1016/s1525-0016(16)44004-9 ◽

2002 ◽

Vol 5 (5) ◽

pp. S382

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Herpes Simplex Virus ◽

Herpes Simplex ◽

Phase I ◽

Thymidine Kinase ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory ◽

Simplex Virus ◽

Therapeutic Responses

Download Full-text

1159. A Phase I/II Study of High Dose Allogeneic GM-CSF Gene-Transduced Prostate Cancer Cell Line Vaccine in Patients with Metastatic Hormone-Refractory Prostate Cancer

Molecular Therapy ◽

10.1016/s1525-0016(16)41601-1 ◽

2003 ◽

Vol 7 (5) ◽

pp. S447 ◽

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Cell Line ◽

Prostate Cancer Cell ◽

Cancer Cell Line ◽

Prostate Cancer Cell Line ◽

High Dose ◽

Hormone Refractory Prostate Cancer ◽

Gm Csf ◽

Hormone Refractory

Download Full-text

Phase I/II study of taxane and estramustine with samarium in patients with hormone refractory prostate cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.4732 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4732-4732

Author(s):

S. L. Arnsmeier ◽

S. Spies ◽

D. Shervin ◽

M. Pins ◽

R. C. Bergan

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

Phase I/II study of taxane and estramustine with samarium in patients with hormone refractory prostate cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.4732 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4732-4732

Author(s):

S. L. Arnsmeier ◽

S. Spies ◽

D. Shervin ◽

M. Pins ◽

R. C. Bergan

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

Phase I study of the novel, oral angiogenesis inhibitor PTK787/ZK 222584 (PTK/ZK): Evaluating the pharmacokinetic effect of a high-fat meal in patients with hormone-refractory prostate cancer (HRPC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.4689 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4689-4689 ◽

Author(s):

D. George ◽

W. Oh ◽

T. Gilligan ◽

E. Masson ◽

C. Souppart ◽

...

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Phase I Study ◽

Angiogenesis Inhibitor ◽

The Novel ◽

Hormone Refractory Prostate Cancer ◽

High Fat ◽

Hormone Refractory ◽

Download Full-text

A phase I study of estramustine, weekly docetaxel and carboplatin (EDC) chemotherapy in patients with hormone refractory prostate cancer (HRPC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.4656 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4656-4656

Author(s):

W. K. Oh ◽

E. Hagmann ◽

J. Manola ◽

D. J. George ◽

T. D. Gilligan ◽

...

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Phase I Study ◽

Hormone Refractory Prostate Cancer ◽

Weekly Docetaxel ◽

Hormone Refractory

Download Full-text

A phase I/II study of docetaxel and atrasentan in men with metastatic hormone-refractory prostate cancer (HRPC)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.4667 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 4667-4667 ◽

Author(s):

D. J. George ◽

J. P. Gockerman ◽

W. Petros ◽

S. Haley ◽

A. D. Franklin ◽

...

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text